Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3212]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
IMW 2013: Cereblon is can predict response to immunomodulatory drug therapy and survival outcomes in multiple myeloma
IMW 2013: Cereblon is can predict response to immunomodulatory drug therapy and survival outcomes in multiple...
IMW 2013: The role of allotransplant in the era of novel therapies for multiple myeloma
IMW 2013: The role of allotransplant in the era of novel therapies for multiple myeloma
IMW 2013: Will consolidation and maintenance become standard of care in the future?
IMW 2013: Will consolidation and maintenance become standard of care in the future?
IMW 2013: Assessing renal impairment in myeloma
IMW 2013: Assessing renal impairment in myeloma
IMW 2013: Daratumumab granted fast track designation by the FDA
IMW 2013: Daratumumab granted fast track designation by the FDA
IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma
IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma
Protein that takes care of our DNA is critical to leukaemia
Protein that takes care of our DNA is critical to leukaemia
IMW 2013: Biomedical imaging in multiple myeloma
IMW 2013: Biomedical imaging in multiple myeloma
New multiple myeloma treatment guidelines personalise therapy for patients
New multiple myeloma treatment guidelines personalise therapy for patients
Telomere protein disrupted in chronic lymphocytic leukaemia
Telomere protein disrupted in chronic lymphocytic leukaemia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation